Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCvc Ig Eur Regulatory News (CVCE)

Share Price Information for Cvc Ig Eur (CVCE)

Share Price is delayed by 15 minutes
Get Live Data
1.07    0.005 (0.47%)
Bid:
1.06
Ask:
1.07
Spread: 0.01 (0.943%)
Market Cap: €298.31m
CVCE Live PriceLast checked at - London Stock Exchange

Intraday Cvc Ig Eur Share Chart

Share Price Movement Update

17 Mar 2026 15:42

RNS Number : 0171X
CVC Income & Growth Limited
17 March 2026
 

17 March 2026

 

CVC Income & Growth Limited

(the Company)

 

Share Price Movement Update

 

The Board of the Company notes the recent share price movements in the Sterling and Euro share classes since the beginning of 2026 and provides the following update.

The Company's Sterling and Euro share price has fallen by more than 8% (as at close of trading on 16 March 2026). This decrease in share price is significantly more than the UBS European Leveraged Loan index which has fallen by 0.81% Year to Date (YTD) and Bloomberg European Leveraged Loan index which has fallen 0.98% YTD. The Board and the Investment Vehicle Manager consider it is reasonable to believe that the underlying portfolio's performance should broadly track the indices.

 

Publicly traded corporate credit versus private credit

The Company provides exposure primarily to publicly traded corporate credit, including syndicated loans and bonds. These assets differ from private credit investments in that they are actively traded in secondary markets and priced daily, rather than typically being priced quarterly which is the case for private credit.

Circa 98% of the loans and bonds within the underlying portfolio are priced daily based on traded broker marks. The Company's shares trade intraday on the London Stock Exchange, providing shareholders with daily secondary market liquidity.

 

Interest rate environment

Recent geopolitical developments and energy market volatility have contributed to increased uncertainty regarding the outlook for inflation and the path of interest rates during 2026. At the beginning of the year, the market had anticipated a series of interest rate reductions from the Bank of England, while the European Central Bank was expected to hold interest rates flat. However, renewed inflationary pressures, driven by energy markets, renewed supply chain issues and geopolitical developments, have contributed to a reassessment of the trajectory for interest rates in both geographies.

The Company's strategy focuses on floating-rate credit instruments, primarily senior secured loans. As a result, the income generated by the underlying portfolio is linked to prevailing base rates. In an environment where the pace of rate reductions is slower than previously anticipated, the portfolio's floating-rate characteristics may support the level of income generated by the underlying assets, subject to broader market conditions and portfolio performance.

 

Exposure to the software sector

Recent media coverage has highlighted concerns around sector concentration in software lending, which in some credit portfolios can represent a significant proportion of assets.

The Company has an exposure of circa 3% to software companies.

The Company's Investment Vehicle Manager notes: "The outlook for 2026 was fairly benign at the start of the year, which was reflected in credit spreads. Since then, markets have repriced software risk in both public equity and public credit markets given the fast-paced developments we've seen in AI. After the recent developments in the Middle East, markets have also started to price in higher for longer oil prices which could result in a slowdown in growth, but also higher inflation, potential supply chain issues and a reduction in consumer confidence. At this point, it's impossible to say where the conflict is heading. The portfolio continues to generate income in line with expectations, but the marks on the underlying assets move on a daily basis reflecting sentiment around the conflict and global growth. Both public equity and credit markets have repriced since the start of the year, resulting in a small negative NAV performance YTD. This shows that public credit markets are functioning."

 

--- END ---

 

Enquiries:

Cadarn Capital

Email: info@cadarncapital.com

 

BNP Paribas S.A. Jersey Branch

Email: cvccpeolcosec@bnpparibas.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDDZGMFKNGGVZM
Date   Source Headline
6th Feb 20251:32 pmRNSIssue of Equity
5th Feb 20254:36 pmRNSIssue of Equity
5th Feb 20253:58 pmRNSDirector/PDMR Shareholding
4th Feb 20253:10 pmRNSHolding(s) in Company
4th Feb 202510:01 amRNSHolding(s) in Company
3rd Feb 20254:58 pmRNSTotal Voting Rights
31st Jan 202510:11 amRNSNet Asset Value Weekly to 24 Jan 2025
30th Jan 20255:14 pmRNSIssue of Equity
29th Jan 20253:13 pmRNSIssue of Equity
27th Jan 20256:15 pmRNSDIVIDEND DECLARATION & DIV TARGET '25(Replacement)
27th Jan 20257:00 amRNSJANUARY 2025 SHARE CONVERSION
24th Jan 20255:25 pmRNSMONTHLY REPORT
24th Jan 20252:30 pmRNSNet Asset Value Weekly to 17 Jan 2025
24th Jan 202512:53 pmRNSDividend Declaration & Annual Dividend target '25
22nd Jan 20255:08 pmRNSIssue of Equity
22nd Jan 20254:00 pmRNSIssue of Equity
21st Jan 20255:09 pmRNSNet Asset Value Month End 31 Dec 2024
17th Jan 20254:25 pmRNSNet Asset Value Weekly to 10 Jan 2025
17th Jan 20253:58 pmRNSIssue of Equity
16th Jan 20251:05 pmRNSIssue of Equity
15th Jan 20254:24 pmRNSIssue of Equity
14th Jan 20254:37 pmRNSIssue of Equity
10th Jan 20254:47 pmRNSHolding(s) in Company
10th Jan 20254:31 pmRNSIssue of Equity
9th Jan 20255:10 pmRNSNet Asset Value Weekly to 03 Jan 2025
9th Jan 20254:44 pmRNSIssue of Equity
8th Jan 20255:00 pmRNSIssue of Equity
7th Jan 20259:09 amRNSMarch 2025 Semi Annual Tender Restrictions
2nd Jan 20255:10 pmRNSNet Asset Value Weekly to 27 Dec 2024
30th Dec 20241:20 pmRNSNet Asset Value Weekly to 20 Dec 2024
20th Dec 20248:54 amRNSMonthly Report
19th Dec 20245:05 pmRNSNet Asset Value Weekly to 13 Dec 2024
18th Dec 202412:09 pmRNSNet Asset Value Month End 29 Nov 2024
17th Dec 20242:42 pmRNSJANUARY 2025 SHARE CONVERSION
12th Dec 20242:29 pmRNSNet Asset Value Weekly to 06 Dec 2024
5th Dec 202412:10 pmRNSNet Asset Value Weekly to 29 Nov 2024
2nd Dec 20249:49 amRNSTotal Voting Rights
28th Nov 20243:30 pmRNSNet Asset Value Weekly to 22 Nov 2024
22nd Nov 20244:26 pmRNSMonthly Report
22nd Nov 20244:25 pmRNSHolding(s) in Company
22nd Nov 20244:10 pmRNSMonthly Report
20th Nov 20245:10 pmRNSNet Asset Value Weekly to 15 Nov 2024
19th Nov 20249:48 amRNSNet Asset Value Month End 31 Oct 2024
15th Nov 20245:00 pmRNSTotal Voting Rights
14th Nov 20245:45 pmRNSNet Asset Value Weekly to 08 Nov 2024
12th Nov 20242:06 pmRNSDirector/PDMR Shareholding
7th Nov 20242:45 pmRNSNet Asset Value Weekly to 01 Nov 2024
31st Oct 20245:00 pmRNSNet Asset Value Weekly to 25 Oct 2024
31st Oct 20247:00 amRNSSeptember 2024 Tender – Purchase of shares
25th Oct 20247:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.